Naming Star Actives: Niacinamide, Retinol, and Their INCI
Marketing names for hero actives usually match their INCI names, but not always exactly. Here is where the two can quietly diverge.
Niacinamide is one of the rare hero ingredients where the marketing name and the INCI name are the same word. That's convenient, and it's also a little misleading, because it trains people to assume every star active works that way. Plenty don't, and the gap between what a bottle's front label calls an ingredient and what actually needs to appear in the ingredient declaration is where filings go sideways.
The easy ones
Niacinamide really is Niacinamide on the INCI declaration. Same spelling, same word, no translation required. That is genuinely one of the simpler active ingredients to file correctly for exactly this reason, and it is part of why it has become such a popular hero ingredient across serums and moisturizers. There is very little room for a labeling mismatch when the marketing name is already the regulatory name.
Where names quietly diverge
Retinol is a good example of a name that is mostly consistent but hides real complexity underneath. "Retinol" as an INCI name refers specifically to the alcohol form of vitamin A. But the retinoid family marketed under vitamin A branding includes several distinct molecules with their own separate INCI names: Retinyl Palmitate is an ester form, Retinaldehyde (sometimes marketed as retinal) is another distinct form, and each is a chemically different substance with a different INCI name and, generally, a different CAS number, even though marketing copy sometimes uses "retinol" loosely to describe the whole family.
This matters because a product marketed with "retinol" language on the front of the package needs to declare whatever specific form is actually in the formula, using that form's own correct INCI name, not a generic catch-all.
A reference table for common hero actives
| Marketing name | INCI name | Notes |
|---|---|---|
| Niacinamide | Niacinamide | Marketing and INCI name match directly |
| Retinol | Retinol | Refers specifically to the alcohol form of vitamin A |
| Retinyl Palmitate | Retinyl Palmitate | A distinct ester form, not interchangeable with Retinol on a filing |
| Vitamin C (as commonly marketed) | Ascorbic Acid, or a derivative like Sodium Ascorbyl Phosphate | "Vitamin C" is a marketing umbrella covering several distinct INCI ingredients |
| Hyaluronic Acid | Sodium Hyaluronate (most common form used) | The salt form is what is typically used in formulas, with its own INCI name |
This table is illustrative, not exhaustive. The pattern to notice is that some marketing names map to exactly one INCI name, while others, particularly "Vitamin C," act as an umbrella term covering multiple genuinely different ingredients that a formulator might choose between, each with its own INCI identity.
Why the umbrella terms cause the most trouble
"Vitamin C" is probably the most common source of confusion because so many different derivatives get marketed under that one consumer-friendly phrase. Ascorbic acid itself is one specific molecule. Sodium Ascorbyl Phosphate is a different, more stable derivative frequently used because it holds up better in formulation. Both get called "Vitamin C" on packaging, but they are not the same ingredient, they do not share a CAS number, and a filing needs to state the one that is actually present, not the umbrella phrase.
The same pattern shows up with "Vitamin E," which usually refers to Tocopherol but sometimes to Tocopheryl Acetate, a related but distinct ester form.
A practical approach for formulators
- When you choose a hero active for a formula, write down its exact INCI name at the moment of formulation, not just the marketing name you plan to use on the front label.
- If your active is part of a family with an umbrella marketing term, like vitamin C or vitamin E, confirm with your supplier exactly which specific derivative you are buying, and use that specific INCI name.
- Never assume two products from different suppliers marketed with the same buzzword contain the same ingredient. Ask for the INCI name every time you source a new active, even if you have used a similarly named active before.
- Keep your marketing copy and your ingredient declaration logically consistent. If your front label says "with retinol" but your formula actually uses Retinyl Palmitate, that mismatch is worth resolving before launch, not after a customer or a regulator asks about it.
Where this fits into filing
Getting the INCI name right for a hero active matters just as much as getting it right for a minor supporting ingredient, since concentration limits, restrictions, and screening all operate on the actual INCI identity, not the marketing story around it. Cosmetic Comply's ingredient matching maps whatever active you list, including common marketing names, to its correct INCI name and CAS number as part of processing your ingredient list, which is a useful check especially for umbrella terms like vitamin C where more than one legitimate answer exists.
Send your ingredients and we take it from here
A short intake form is all it takes to start. Every ingredient gets checked against your market's prohibited and restricted lists, then we file your notification and hand you a number you can track.
Start a filingKeep reading
Fragrance Oil Versus Essential Oil on Your Ingredient List
A synthetic fragrance blend and a single essential oil declare very differently on a CNF. Here is how each one actually gets named.
pH Adjusters on a Filing: Citric Acid and Its Solution
A citric acid solution from your supplier isn't pure citric acid. Here is what actually goes on your ingredient list, and why water matters.
Turning supplier trade names into INCI names
Your supplier calls it Crodamol, the regulator wants Isopropyl Myristate. Here is how to bridge trade names to INCI without guessing, and where the blends will trip you up.
Essential Oil INCI Versus Its Individual Constituents
Declaring lavender oil as one line item works until an allergen constituent inside it needs its own separate disclosure.